Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for inpatient cannabis withdrawal
ACTRN12614000248662Phase 2Not yet recruiting
- Sponsor
- University of New South Wales
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cannabidiol in cannabis withdrawal, sponsored by University of New South Wales. Primary endpoint: Reduction in number and severity of withdrawal symptoms. Planned start Mar 2014; status: not yet recruiting.
02
Drugs
cannabidiol
03
Conditions
cannabis withdrawal
Beyond the preview
Go deeper on ACTRN12614000248662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000248662.